Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Wyeth: Domestic Centrum sales rose 6% to $93.7 mil. in Q2, making it the only consumer brand of seven broken out by Wyeth to post positive U.S. results in the period. Brand revenue may have been helped by launch of Centrum Performance energy nutrition bars, in stores now (1"The Tan Sheet" May 6, 2002, p. 9). Advil sales fell 11.1% to $93.2 mil. in the U.S., while domestic Caltrate sales were off 10.6% at $15.2 mil. Similar to other cough/cold product manufacturers, Wyeth's financials were negatively impacted by a mild U.S., winter, with both Robitussin (down 9.7%) and Dimetapp (off 8.1%) feeling the effects. Consumer healthcare sales dropped 4% in U.S. to $308.4 mil. and were flat worldwide at $493.1 mil., Wyeth says in 2July 23 earnings release...
You may also be interested in...
Nicorette International Growth Integral To Pfizer OTC Strength – Hassan
Nicorette gum will be one of the driving forces behind Pfizer's international consumer business, Pharmacia Chairman & CEO Fred Hassan predicted July 15
Centrum Performance Energy Nutrition Bars: Wyeth’s Functional Food Debut
Wyeth Consumer Healthcare is looking to build on the success of its Centrum franchise with the launch of Centrum Performance energy nutrition bars, the firm's first functional food
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7